Menu
Products
COVID-19 Antigens
-
Use Sengenics’ correctly folded spike, nucleocapsid or envelope COVID-19 antigens for production of a high-affinity vaccine
-
Development of an antigen-based COVID-19 sero-diagnostic test for patient screening or immunosurveillance purposes
-
Fundamental research: characterisation of full-length, correctly folded and functional SARS-CoV-2 antigens
ImmuSAFE COVID+ Biochip Test
-
World’s first high-throughput, multi-domain COVID-19 antibody test
-
Population antibody profiling for seroprevalence research
-
Determine the protective quality and quantity of antibodies produced
-
Enable quantitative assessment of antigen-specific response by individuals in vaccine trials
IMMUNOME Protein Array
- High-throughput platform for autoantibody biomarker discovery and protein-protein interactions
- Exploratory arrays capable of screening over 1600 proteins in quadruplicate
- Picogram level sensitivity – fully quantitative assay
- Exceptional consistency and batch-to-batch reproducibility
CTA Array
- High-throughput quantification of autoantibodies to Cancer-Testis (CT) antigens
- Patient stratification in checkpoint inhibitor studies
- Picogram level sensitivity – fully quantitative assay
- Exceptional consistency and batch-to-batch reproducibility
Custom Arrays
- Parallel screening of multiple samples on one slide
- Proteins can be selected from our existing library or can be custom made
- Choose from 2, 4, 8 or 16-plex format
- Bespoke content and project design service
OncoREX p53 Cancer Array
- Cancer drug screening and discovery
- Screen 100 mutant p53 protein array in one experiment
- Same chip can also be used for aAb specificity and analysis
- Protein spotted in triplicate
© 2008 – 2021 Sengenics All rights reserved | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D | Sengenics UK Ltd. Registered in England and Wales No 11016361
